Subunit approach to evaluation of the immune protective potential of leptospiral antigens

Clinical and Vaccine Immunology

Volumn 18, Issue 12, 2011, Pages 2026-2030

  Félix, Samuel R ^a   Hartwig, Daiane D ^a   Argondizzo, Ana Paula C ^b   Silva, Éverton F ^a   Seixas, Fabiana K ^a   Seixas Neto, Amilton C P ^a   Medeiros, Marco A ^b   Lilenbaum, Walter ^c   Dellagostin, Odir A ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b Instituto de Technologia em Imunobiologicos   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT LIC10009 ANTIGEN VACCINE; RECOMBINANT LIC10011 ANTIGEN VACCINE; RECOMBINANT LIC10021 ANTIGEN VACCINE; RECOMBINANT LIC10054 ANTIGEN VACCINE; RECOMBINANT LIC10091 ANTIGEN VACCINE; RECOMBINANT LIC10191 ANTIGEN VACCINE; RECOMBINANT LIC10325 ANTIGEN VACCINE; RECOMBINANT LIC10501 ANTIGEN VACCINE; RECOMBINANT LIC10508 ANTIGEN VACCINE; RECOMBINANT LIC10561 ANTIGEN VACCINE; RECOMBINANT LIC10645 ANTIGEN VACCINE; RECOMBINANT LIC11087 ANTIGEN VACCINE; RECOMBINANT LIC11184 ANTIGEN VACCINE; RECOMBINANT LIC11567 ANTIGEN VACCINE; RECOMBINANT LIC11859 ANTIGEN VACCINE; RECOMBINANT LIC11947 ANTIGEN VACCINE; RECOMBINANT LIC12099 ANTIGEN VACCINE; RECOMBINANT LIC12253 ANTIGEN VACCINE; RECOMBINANT LIC12538 ANTIGEN VACCINE; RECOMBINANT LIC12555 ANTIGEN VACCINE; RECOMBINANT LIC12632 ANTIGEN VACCINE; RECOMBINANT LIC12730 ANTIGEN VACCINE; RECOMBINANT LIC13006 ANTIGEN VACCINE; RECOMBINANT LIC13059 ANTIGEN VACCINE; RECOMBINANT LIC13305 ANTIGEN VACCINE; RECOMBINANT LIC13306 ANTIGEN VACCINE; RECOMBINANT LIC20172 ANTIGEN VACCINE; RECOMBINANT VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HAMSTER; IMMUNE RESPONSE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; PROTEIN SUBUNITS; SURVIVAL ANALYSIS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 83455259664     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05297-11     Document Type: Article

References (29)

1. Adler, B., and A. de la Peña-Moctezuma. 2010. Leptospira and leptospirosis. Vet. Microbiol. 140:287-296.
2. Atzingen, M. V., et al. 2010. Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans. J. Med. Microbiol. 59:1005-1015.
3. Bharti, A. R., et al. 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3:757-771. (Pubitemid 37489960)
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Branger, C., et al. 2005. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect. Immun. 73:4062-4069. (Pubitemid 40923146)
6. Branger, C., et al. 2001. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect. Immun. 69:6831-6838. (Pubitemid 32995442)
7. Cerqueira, G. M., and M. Picardeau. 2009. A century of Leptospira strain typing. Infect. Genet. Evol. 9:760-768.
8. Chang, Y. F., et al. 2007. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine 25:8190-8197.
9. Croda, J., et al. 2008. Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis. Infect. Immun. 76:5826-5833.
10. Cullen, P. A., D. A. Haake, and B. Adler. 2004. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol. Rev. 28:291-318. (Pubitemid 38721407)
11. Faine, S. B., B. Adler, C. Bolin, and P. Perolat. 1999. Leptospira and leptospirosis, 2nd ed. MedSci, Melbourne, Australia.
12. Faisal, S. M., et al. 2008. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26:277-287. (Pubitemid 350266122)
13. Felix, S. R., et al. 2009. Leptospirosis vaccine: search for subunit candidates. Procedia Vaccinol. 1:110-114.
14. Gamberini, M., et al. 2005. Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol. Lett. 244:305-313. (Pubitemid 40342843)
15. Haake, D. A., et al. 1999. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect. Immun. 67:6572-6582.
16. Hartwig, D. D., F. K. Seixas, G. M. Cerqueira, A. J. McBride, and O. A. Dellagostin. 2011. Characterization of the immunogenic and antigenic potential of putative lipoproteins from Leptospira interrogans. Curr. Microbiol. 62:1337-1341.
17. Hotez, P. J., and M. T. Ferris. 2006. The antipoverty vaccines. Vaccine 24:5787-5799. (Pubitemid 43947393)
18. Ko, A. I., C. Goarant, and M. Picardeau. 2009. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol. 7:736-747.
19. Koizumi, N., and H. Watanabe. 2004. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22:1545-1552. (Pubitemid 38446933)
20. Lin, Y. P., and Y. F. Chang. 2007. A domain of the Leptospira LigB contributes to high affinity binding of fibronectin. Biochem. Biophys. Res. Commun. 362:443-448.
21. McBride, A. J., D. A. Athanazio, M. G. Reis, and A. I. Ko. 2005. Leptospirosis. Curr. Opin. Infect. Dis. 18:376-386. (Pubitemid 41345294)
22. Murray, G. L., et al. 2009. Genome-wide transposon mutagenesis in pathogenic Leptospira species. Infect. Immun. 77:810-816.
23. Nascimento, A. L., et al. 2004. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J. Bacteriol. 186:2164-2172. (Pubitemid 38381206)
24. Palaniappan, R. U., et al. 2006. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect. Immun. 74:1745-1750. (Pubitemid 43346809)
25. Ramos, C. R., P. A. Abreu, A. L. Nascimento, and P. L. Ho. 2004. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz. J. Med. Biol. Res. 37:1103-1109. (Pubitemid 39172546)
26. Seixas, F. K., et al. 2007. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88-95. (Pubitemid 350213201)
27. Silva, E. F., et al. 2007. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277-6286. (Pubitemid 47088033)
28. Silva, E. F., et al. 2008. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 26:3892-3896.
29. Wang, Z., L. Jin, and A. Wegrzyn. 2007. Leptospirosis vaccines. Microb. Cell Fact. 6:39.